DataMEDS AI, Inc. (MEDS : NASDAQ)
Common Stock
$6.07
USD
+4.45 (274.69%)
Last updated: 2026-09-16
Get MEDS alerts:
MEDS
DataMEDS AI, Inc.
Performance
1 Day
+274.69%
1 Week
+613.28%
1 Month
+307.38%
YTD
+64.05%
Key Statistics
Market Cap
$18.59M
52W High
$75.00
52W Low
$0.82
P/E Ratio
-
50 Day MA
$2.06
200 Day MA
$9.42
Beta
-
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/16/2026 | $4.04 | $12.31 | $4.00 | $6.07 | $6.07 | 186,414,876 |
| 9/15/2026 | $0.89 | $3.85 | $0.86 | $1.62 | $1.62 | 65,061,223 |
| 9/14/2026 | $0.88 | $0.90 | $0.86 | $0.87 | $0.87 | 56,673 |
| 9/11/2026 | $0.91 | $0.94 | $0.86 | $0.90 | $0.90 | 87,965 |
| 9/10/2026 | $0.88 | $0.90 | $0.85 | $0.89 | $0.89 | 79,700 |
| 9/9/2026 | $0.87 | $0.95 | $0.85 | $0.85 | $0.85 | 148,600 |
| 9/8/2026 | $0.92 | $0.92 | $0.85 | $0.87 | $0.87 | 135,800 |
| 9/4/2026 | $0.97 | $1.04 | $0.92 | $0.92 | $0.92 | 311,500 |
| 9/3/2026 | $1.02 | $1.03 | $0.95 | $0.96 | $0.96 | 52,000 |
| 9/2/2026 | $0.97 | $1.05 | $0.93 | $1.03 | $1.03 | 120,600 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MEDS's historical volatility
30-Day Vol
456.0%
Annualized
90-Day Vol
327.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$7.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.44 | US$1.34 – US$31.07 |
| 60 trading days | US$6.84 | US$0.74 – US$63.29 |
| 90 trading days | US$7.26 | US$0.48 – US$110.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About DataMEDS AI, Inc.
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Financials
- Revenue (TTM)
- $8.02M
- EBITDA
- $-55.39M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -48.30
- Book Value
- -6.88
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MEDS.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.19 | +41.54% |